Both in Pharmaceuticals
Canopy Growth vs Enanta Pharmaceuticals
Over the past year CGC returned −49.4% and ENTA returned +14.3%; their daily moves had a correlation of 0.18.
CGC −49.4% ENTA +14.3%Growth of $1, one year, split-adjusted
| Metric | CGC | ENTA |
|---|---|---|
| Price | $0.6681 | $12.00 |
| Market cap | $282.6M | $349.5M |
| Today | −1.14% | +3.09% |
| 1 month | −29.0% | +1.0% |
| 6 months | −44.3% | −9.6% |
| Year to date | −41.4% | −23.9% |
| 1 year | −49.4% | +12.5% |
| Revenue growth (YoY) | +7.8% | −21.6% |
| Gross margin | 27.4% | 100.0% |
| Net margin | −18.0% | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 5.4× |
| Net cash | $67.9M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 41.3% | 44.2% |
| Short % of float | 7.5% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).